Clinical Trials Browser

Phase 1 × Completed × Dementia × Clear all

NCT05328115 2025-01-31

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

Phase 1 Completed

Alzheimer Disease, Dementia, Lymphoma, Follicular